openPR Logo
Press release

Global Bipolar Disorder Market Size, Industry Share, Growth & Forecast To 2025

05-14-2020 01:00 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

The global bipolar disorder market is projected to exhibit a significant growth, at a CAGR of around 2.7%, during the forecast period. The major factors that are primarily driving the growth of the market include the increased levels of stress at the workplace, emerging awareness regarding stress management, and growing insurance claims for mental health. As per IHME, in 2017, there was 4.12% of the total population suffering from depression in UK. Moreover, around 4.65% share of the total population was recorded for anxiety and 1.09% of people suffered from bipolar disorder. Therefore, these significant shares of behavioral disorders in UK create substantial demand for bipolar disorder treatment that further contributes to market growth.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/bipolar-disorder-market

In recent times, there are an increasing number of insurance claims for mental health across the globe. Claims related to depression, anxiety, and other mental conditions are on the rise. Several countries have started including mental illness into medical claims including the US, UK, and India. For instance, in 2017, the Indian government announced the Mental Healthcare Act that supports any guarantor offering health insurance plans to cater to mental illness policyholders the same way they cater to physical illnesses or accidents. In addition, it ensures that an insurer cannot discriminate an illness in being mental or physical. Therefore, it is one of the major factors that assist in the growth of the bipolar disorder market.

A Full Report of Global Bipolar Disorder Market is Available at: https://www.omrglobal.com/industry-reports/bipolar-disorder-market

According to the FAIR Health report, mental health-related claims are growing at a substantial rate where the claim was 1.8% of all medical claims in 2012 and it grew to 2.7% in 2017 which was an approximate 50% increase in claims in just 6 years. Further, claims for mental health rose among young individuals, which is a categorized age of less than 22. Additionally, young people accounted for an increasing share of the claims for MDD as per the report. The young individuals accounted for 15% of all claims bound to serious depression in 2007 and increased to 23% in 2017.

Furthermore, anxiety is one of the most common mental disorders among young people. From 2007 to 2017, among young people aged 19 to 22, generalized anxiety disorder has increased significantly during this period, as per the FAIR Health report. There was also a significant increase in mental disorders related to anxiety among teenagers and children. The report also found that from 2007 to 2017, claim lines for diagnosis of behavioral health increased by 108%. In 2017, the behavioral health disorder listed 2.7% of all lines of medical claims in the database of FAIR Health. The most common diagnosis among these claims of mental health was MDD, which in 2017 accounted for 26% of claims of mental health. There was also a significant increase in claim lines for a generalized anxiety disorder during that period, which in turn, assists in the growth of the bipolar disorder market.

Global Bipolar Disorder Market-Segmentation

By Type

Bipolar Disorder I
Bipolar Disorder II
Others (Cyclothymic Disorder)

By Treatment

Drugs & Medications

o Anticonvulsants

o Antidepressants

o Antipsychotics

o Others (Mood Stabilizers)

Therapy & Devices/Apps

By Mechanism of Action

Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
Benzodiazepines
Beta Blockers
Others (Tricyclic Antidepressants (TCAs))

Global Bipolar Disorder Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
Middle East and Africa

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/bipolar-disorder-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Bipolar Disorder Market Size, Industry Share, Growth & Forecast To 2025 here

News-ID: 2045681 • Views:

More Releases from Orion Market Research

Microfinance Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Microfinance Market Size, Trends, Latest Insights, Analysis and Forecast 2024-20 …
The global microfinance market is anticipated to grow at a considerable CAGR of around 14.8% during the forecast period (2024-2031). The market growth is driven by the rising demand for finance among the low-income and more overlooked sections of society, government support, and the continuous establishment of microfinance institutions across the globe. The World Bank estimated that over 7,000 microfinance institutions are operating across the globe, serving nearly 16 million
Oral and Dental Probiotics Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Oral and Dental Probiotics Market Size, Trends, Latest Insights, Analysis and Fo …
The global oral and dental probiotics market is anticipated to grow at a CAGR of 8.5% during the forecast period (2024-2031). The market growth is driven by the rising awareness about the oral health benefits associated with oral and dental probiotics. The industry growth is also driven by the increasing popularity of combination products, which integrate probiotics with other oral health-enhancing ingredients. Additionally, the rising preference for natural and preventive
Wireless Health Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Wireless Health Market Size, Trends, Latest Insights, Analysis and Forecast 2024 …
The global wireless health market is anticipated to grow at a significant CAGR of approx. 22.3% during the forecast period (2024-2031). The market growth is driven by the increase demand for chronic disease management solutions, fitness tracking, supporting medication adherence, hampering hospital readmissions, symptom tracking, and managing mental & behavioral health. Additionally, the evolution of healthcare IT is also contributing to market growth through the integration of the Internet of
Antiallergic Non-Drug Supplement Market Will Exhibit an Impressive Expansion by 2024-2031 | General Nutrition Center Holdings, LLC (GNC), Emerald Laboratories
Antiallergic Non-Drug Supplement Market Will Exhibit an Impressive Expansion by …
Antiallergic Non-Drug Supplement Market is anticipated to grow at a significant CAGR during the forecast period. An antiallergic non-drug supplement is a medicinal product that includes various types of nutritional supplements, oils, among others. These supplements are categorized into tablets, capsules, and liquid dosage forms. Antiallergic non-drug supplements can alleviate various types of allergic symptoms and enable allergic patients to deal with the allergic symptoms without using any chemical-based formulations

All 5 Releases


More Releases for Disorder

Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior. Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms
Autism Spectrum Disorder (ASD) Treatment Market Report 2018: Segmentation by Aut …
Global Autism Spectrum Disorder (ASD) Treatment market research report provides company profile for Roche Pharmaceuticals, Autism Treatment Plus, Fraser, Retrophin, Inc., Autism Services Inc., Pfizer Inc., SynapDx, Behavior Analysis, Inc., Autism Therapeutics, Curemark LLC and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,
Speech Therapy Service Market Report 2018: Segmentation by Product (Speech Disor …
Global Speech Therapy Service market research report provides company profile for Benchmark Therapies, Talk Speech, Language Therapy, Speech Plus, Smart Speech Therapy, Therapy Solutions, Glenda Browne Speech Pathology and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
Thyroid Gland Disorder Treatment Market: Increasing incidence of Autoimmune Dise …
The global market for thyroid gland disorders features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of